Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Precision Antibacterial Company Raises $35M in New Funds

E. coli bacteria

A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds

Trial Shows Gene Therapy Results with Sickle Cell Disease

Sickle cells illustration

Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease

Early Trial Data Show Crispr Cancer Therapy Response

Crispr genome edits illustration

Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects. . . . → Read More: Early Trial Data Show Crispr Cancer Therapy Response

Trial Set for Ingested Colon Cancer Detection Capsule

Detect cancer scrabble

A clinical trial is set to begin assessing an electronic capsule designed to detect and transmit images from the gut to detect early cancer-causing polyps. . . . → Read More: Trial Set for Ingested Colon Cancer Detection Capsule

Small Biz Grant Funds Mental Health App Clinical Trial

Hands covering face

National Institute of Mental Health is funding a clinical trial to evaluate a home-based mobile app that works online with a clinician to treat depression. . . . → Read More: Small Biz Grant Funds Mental Health App Clinical Trial

Virtual Reality Studied for Chronic Cancer Pain

Woman with VR headset

A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients. . . . → Read More: Virtual Reality Studied for Chronic Cancer Pain

Trial Begins for Skin-Implanted Addiction Therapy

Ambulance at night

A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks. . . . → Read More: Trial Begins for Skin-Implanted Addiction Therapy

State Grant Funds Virus-Immunotherapy Cancer Trial

T-cells and cancer cells

A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial

Early Trials Show Responses for Some Blood Cancers

Natural killer cell

First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers

Trial Begins Testing Crispr Gut Microbiome Therapy

E. coli

A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy